Carnegie Global Healthcare

The fund's investment objective is to seek capital appreciation by investing exclusively in equities of companies in biotechnology, healthcare services, medical technology and pharmaceuticals. An investment in the strategy gives exposure to an interesting but complex arena characterized by new scientific discoveries and strong growth. The fund may be leveraged up to 35 per cent of the value of its net assets for investment purposes.